Kymera Therapeutics, Inc.

KYMR

$56.29

Name : Kymera Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $4,024,600,064.00

EPSttm : -3.49

Kymera Therapeutics, Inc.

$56.29

1.11%

$0.63

Float Short %

12.62

Margin Of Safety %

Put/Call OI Ratio

0.42

EPS Next Q Diff

0.06

EPS Last/This Y

-0.44

EPS This/Next Y

-0.67

Price

56.33

Target Price

64.33

Analyst Recom

1.05

Performance Q

24.51

Relative Volume

0.62

Beta

2.33

Ticker: KYMR

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	KYMR	43.43	0.32	999.99	2051
2025-09-10	KYMR	43.48	0.32	0.67	2052
2025-09-11	KYMR	46.22	0.32	0.01	2055
2025-09-12	KYMR	47	0.32	0.33	2073
2025-09-15	KYMR	47.28	0.32	0.00	2075
2025-09-16	KYMR	48.74	0.32	2.00	2075
2025-09-17	KYMR	48.12	0.32313575525813	0.31868131868132	2076
2025-09-18	KYMR	51.19	0.33	2.59	2162
2025-09-19	KYMR	49.1	0.37	0.01	2274
2025-09-22	KYMR	51	0.39	1.04	2152
2025-09-23	KYMR	50.85	0.41	0.13	2231
2025-09-24	KYMR	52.49	0.41	0.08	2258
2025-09-25	KYMR	53.75	0.40	0.08	2295
2025-09-26	KYMR	56.26	0.39	0.03	2329
2025-09-29	KYMR	58.52	0.37	0.40	2446
2025-09-30	KYMR	56.6	0.38	2.19	2528
2025-10-01	KYMR	54.69	0.40	1.43	2572
2025-10-02	KYMR	56	0.41	0.79	2625
2025-10-03	KYMR	57.92	0.42	0.47	2678
2025-10-06	KYMR	57.53	0.42	0.64	2768
2025-10-07	KYMR	56.91	0.41	2.43	2768
2025-10-08	KYMR	56.32	0.42	36.67	2791
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	KYMR	43.44	-0.5	-42.9	-3.39
2025-09-10	KYMR	43.51	-0.5	-41.5	-3.39
2025-09-11	KYMR	46.20	-0.5	-65.6	-3.39
2025-09-12	KYMR	46.93	-0.5	-47.5	-3.39
2025-09-15	KYMR	47.28	-0.5	-43.7	-3.39
2025-09-16	KYMR	48.78	-0.5	-53.5	-3.39
2025-09-17	KYMR	48.16	-0.5	-36.5	-3.39
2025-09-18	KYMR	51.15	-1.9	-65.3	-3.39
2025-09-19	KYMR	49.10	-1.9	-25.9	-3.39
2025-09-22	KYMR	51.01	-1.9	-55.8	-3.42
2025-09-23	KYMR	50.89	-1.9	-40.5	-3.42
2025-09-24	KYMR	52.49	-1.9	-53.4	-3.42
2025-09-25	KYMR	53.74	-1.9	-50.1	-3.42
2025-09-26	KYMR	56.25	-1.9	-58.7	-3.42
2025-09-29	KYMR	58.52	-1.9	-56.2	-3.42
2025-09-30	KYMR	56.65	-1.9	-29.7	-3.42
2025-10-01	KYMR	54.69	-1.9	-28.8	-3.42
2025-10-02	KYMR	55.97	-1.9	-50.2	-3.42
2025-10-03	KYMR	57.93	-1.9	-54.0	-3.42
2025-10-06	KYMR	57.59	-1.9	-51.8	-3.42
2025-10-07	KYMR	56.88	-1.9	-37.0	-3.42
2025-10-08	KYMR	56.33	-1.9	-37.5	-3.42
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	KYMR	7.75	13.77	12.94
2025-09-10	KYMR	7.75	13.77	12.94
2025-09-11	KYMR	7.75	13.77	13.88
2025-09-12	KYMR	7.75	13.77	13.83
2025-09-15	KYMR	7.91	13.87	13.83
2025-09-16	KYMR	7.63	13.87	13.83
2025-09-17	KYMR	6.90	13.87	13.83
2025-09-18	KYMR	6.90	13.87	13.83
2025-09-19	KYMR	6.90	13.87	13.82
2025-09-22	KYMR	6.91	13.87	13.82
2025-09-23	KYMR	6.91	13.87	13.82
2025-09-24	KYMR	6.91	13.87	13.82
2025-09-25	KYMR	6.91	13.87	12.62
2025-09-26	KYMR	6.91	13.87	12.62
2025-09-29	KYMR	6.91	13.71	12.62
2025-09-30	KYMR	6.91	13.71	12.62
2025-10-01	KYMR	6.91	13.71	12.62
2025-10-02	KYMR	6.91	13.71	12.62
2025-10-03	KYMR	6.91	13.71	12.62
2025-10-06	KYMR	6.91	7.58	12.62
2025-10-07	KYMR	6.91	7.58	12.62
2025-10-08	KYMR	6.91	7.58	12.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.95

Avg. EPS Est. Current Quarter

-0.84

Avg. EPS Est. Next Quarter

-0.89

Insider Transactions

6.91

Institutional Transactions

7.58

Beta

2.33

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

38.7

Max Drawdown 5-Year %

-87.5

Target Price

64.33

P/E

Forward P/E

PEG

P/S

90.02

P/B

4.09

P/Free Cash Flow

EPS

-3.48

Average EPS Est. Cur. Y

-3.42

EPS Next Y. (Est.)

-4.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-616.03

Relative Volume

0.62

Return on Equity vs Sector %

-53.6

Return on Equity vs Industry %

-39.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-37.5

Kymera Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 218

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

stock quote shares KYMR – Kymera Therapeutics, Inc. Stock Price stock today

news today KYMR – Kymera Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KYMR – Kymera Therapeutics, Inc. yahoo finance google finance

stock history KYMR – Kymera Therapeutics, Inc. invest stock market

stock prices KYMR premarket after hours

ticker KYMR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: KYMR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y